Enzyme Activity Assays Market

Future Market Insights analysis shows that the shift toward precision medicine and biologics-driven pipelines will accelerate demand for high-throughput, target-specific enzyme activity assays, reinforced by pharma-scale portfolio expansion such as Pfizer’s precision oncology strategy and reagent innovation milestones like Revvity’s pHSense™ platform, positioning enzyme assays as core analytical infrastructure rather than auxiliary research tools over the forecast period.